Industry: Chemical & Material
Published Date: 2024-01-18
Pages: 81 Pages
Report ld: 2326745
Request Sample
Customized Report
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Activated charcoal has been used as an oral medicine for a long time, and in the rescue and treatment of patients with acute transoral poisoning, medicinal activated charcoal is one of the important basic rescue measures, which can obviously reduce the absorption of poison and increase the excretion and removal of poison, and obviously improve the success rate of rescue of patients with transoral poisoning. Oral administration of activated carbon is an effective method to reduce the absorption of poisons taken by patients. As an excellent adsorbent material, activated carbon is not only used for oral adsorption and detoxification in emergency medicine, but also widely used as a blood perfusion adsorbent for artificial organ adsorption preparations, for specific central nervous system, for treating certain previously incurable diseases, and in recent years it has also been used as a drug carrier for solutes, for treating malignant tumors Lymph nodes, for guiding the removal of metastatic lymph nodes, and for adjust the pore size of activated carbon and its distribution so that it can absorb various harmful substances and bacteria.
Units: The units in this report refer to the basic quantity units of statistics, such as tablets (Changtian Pharmaceuticals) for the tablet type, and capsules and pills for the pill type, such as Wuxi Ji Yu Shanhe Pharmaceuticals. The unit of product for bag type or granule type is bag.
The key manufacturers of pharmaceutical activated carbon in the Chinese market are Jemincare, Changtian Pharma, Kureha, Myvitamins, etc. The top two manufacturers account for 99% of the market share, with the largest manufacturer being Jemincare with 89%. Production areas are mainly located in Europe, China, Japan, etc. In terms of product type, activated carbon tablets/granules occupy the major market share, accounting for 90%, followed by activated carbon capsules, accounting for about 10%. In terms of application, the pharmacy channel is the top application area, accounting for 70% of the total, while the prescription channel accounts for 28%.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Activated Carbon, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Activated Carbon by region & country, by Type, and by Distribution Channel.
The Pharmaceutical Activated Carbon market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Activated Carbon.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Activated Carbon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pharmaceutical Activated Carbon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pharmaceutical Activated Carbon in country level. It provides sigmate data by Type, and by Distribution Channel for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Activated Carbon Product Introduction
1.2 Global Pharmaceutical Activated Carbon Market Size Forecast
1.2.1 Global Pharmaceutical Activated Carbon Sales Value (2019-2030)
1.2.2 Global Pharmaceutical Activated Carbon Sales Volume (2019-2030)
1.2.3 Global Pharmaceutical Activated Carbon Sales Price (2019-2030)
1.3 Pharmaceutical Activated Carbon Market Trends & Drivers
1.3.1 Pharmaceutical Activated Carbon Industry Trends
1.3.2 Pharmaceutical Activated Carbon Market Drivers & Opportunity
1.3.3 Pharmaceutical Activated Carbon Market Challenges
1.3.4 Pharmaceutical Activated Carbon Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Activated Carbon Players Revenue Ranking (2023)
2.2 Global Pharmaceutical Activated Carbon Revenue by Company (2019-2024)
2.3 Global Pharmaceutical Activated Carbon Players Sales Volume Ranking (2023)
2.4 Global Pharmaceutical Activated Carbon Sales Volume by Company Players (2019-2024)
2.5 Global Pharmaceutical Activated Carbon Average Price by Company (2019-2024)
2.6 Key Manufacturers Pharmaceutical Activated Carbon Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Pharmaceutical Activated Carbon Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pharmaceutical Activated Carbon
2.9 Pharmaceutical Activated Carbon Market Competitive Analysis
2.9.1 Pharmaceutical Activated Carbon Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Activated Carbon Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Activated Carbon as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pharmaceutical Activated Carbon Capsule
3.1.2 Pharmaceutical Activated Carbon Tablet
3.1.3 Others
3.2 Global Pharmaceutical Activated Carbon Sales Value by Type
3.2.1 Global Pharmaceutical Activated Carbon Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmaceutical Activated Carbon Sales Value, by Type (2019-2030)
3.2.3 Global Pharmaceutical Activated Carbon Sales Value, by Type (%) (2019-2030)
3.3 Global Pharmaceutical Activated Carbon Sales Volume by Type
3.3.1 Global Pharmaceutical Activated Carbon Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Pharmaceutical Activated Carbon Sales Volume, by Type (2019-2030)
3.3.3 Global Pharmaceutical Activated Carbon Sales Volume, by Type (%) (2019-2030)
3.4 Global Pharmaceutical Activated Carbon Average Price by Type (2019-2030)
4 Segmentation by Distribution Channel
4.1 Introduction by Distribution Channel
4.1.1 Drug Stores
4.1.2 Prescription Drug
4.2 Global Pharmaceutical Activated Carbon Sales Value by Distribution Channel
4.2.1 Global Pharmaceutical Activated Carbon Sales Value by Distribution Channel (2019 VS 2023 VS 2030)
4.2.2 Global Pharmaceutical Activated Carbon Sales Value, by Distribution Channel (2019-2030)
4.2.3 Global Pharmaceutical Activated Carbon Sales Value, by Distribution Channel (%) (2019-2030)
4.3 Global Pharmaceutical Activated Carbon Sales Volume by Distribution Channel
4.3.1 Global Pharmaceutical Activated Carbon Sales Volume by Distribution Channel (2019 VS 2023 VS 2030)
4.3.2 Global Pharmaceutical Activated Carbon Sales Volume, by Distribution Channel (2019-2030)
4.3.3 Global Pharmaceutical Activated Carbon Sales Volume, by Distribution Channel (%) (2019-2030)
4.4 Global Pharmaceutical Activated Carbon Average Price by Distribution Channel (2019-2030)
5 Segmentation by Region
5.1 Global Pharmaceutical Activated Carbon Sales Value by Region
5.1.1 Global Pharmaceutical Activated Carbon Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmaceutical Activated Carbon Sales Value by Region (2019-2024)
5.1.3 Global Pharmaceutical Activated Carbon Sales Value by Region (2025-2030)
5.1.4 Global Pharmaceutical Activated Carbon Sales Value by Region (%), (2019-2030)
5.2 Global Pharmaceutical Activated Carbon Sales Volume by Region
5.2.1 Global Pharmaceutical Activated Carbon Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Pharmaceutical Activated Carbon Sales Volume by Region (2019-2024)
5.2.3 Global Pharmaceutical Activated Carbon Sales Volume by Region (2025-2030)
5.2.4 Global Pharmaceutical Activated Carbon Sales Volume by Region (%), (2019-2030)
5.3 Global Pharmaceutical Activated Carbon Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Pharmaceutical Activated Carbon Sales Value, 2019-2030
5.4.2 North America Pharmaceutical Activated Carbon Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Pharmaceutical Activated Carbon Sales Value, 2019-2030
5.5.2 Europe Pharmaceutical Activated Carbon Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical Activated Carbon Sales Value, 2019-2030
5.6.2 Asia Pacific Pharmaceutical Activated Carbon Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Pharmaceutical Activated Carbon Sales Value, 2019-2030
5.7.2 South America Pharmaceutical Activated Carbon Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical Activated Carbon Sales Value, 2019-2030
5.8.2 Middle East & Africa Pharmaceutical Activated Carbon Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Activated Carbon Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmaceutical Activated Carbon Sales Value
6.2.1 Key Countries/Regions Pharmaceutical Activated Carbon Sales Value, 2019-2030
6.2.2 Key Countries/Regions Pharmaceutical Activated Carbon Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Pharmaceutical Activated Carbon Sales Value, 2019-2030
6.3.2 United States Pharmaceutical Activated Carbon Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmaceutical Activated Carbon Sales Value by Distribution Channel, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmaceutical Activated Carbon Sales Value, 2019-2030
6.4.2 Europe Pharmaceutical Activated Carbon Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmaceutical Activated Carbon Sales Value by Distribution Channel, 2023 VS 2030
6.5 China
6.5.1 China Pharmaceutical Activated Carbon Sales Value, 2019-2030
6.5.2 China Pharmaceutical Activated Carbon Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmaceutical Activated Carbon Sales Value by Distribution Channel, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmaceutical Activated Carbon Sales Value, 2019-2030
6.6.2 Japan Pharmaceutical Activated Carbon Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmaceutical Activated Carbon Sales Value by Distribution Channel, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmaceutical Activated Carbon Sales Value, 2019-2030
6.7.2 South Korea Pharmaceutical Activated Carbon Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmaceutical Activated Carbon Sales Value by Distribution Channel, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Activated Carbon Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmaceutical Activated Carbon Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmaceutical Activated Carbon Sales Value by Distribution Channel, 2023 VS 2030
6.9 India
6.9.1 India Pharmaceutical Activated Carbon Sales Value, 2019-2030
6.9.2 India Pharmaceutical Activated Carbon Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmaceutical Activated Carbon Sales Value by Distribution Channel, 2023 VS 2030
7 Company Profiles
7.1 Jemincare
7.1.1 Jemincare Company Information
7.1.2 Jemincare Introduction and Business Overview
7.1.3 Jemincare Pharmaceutical Activated Carbon Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Jemincare Pharmaceutical Activated Carbon Product Offerings
7.1.5 Jemincare Recent Development
7.2 Changtian Pharma
7.2.1 Changtian Pharma Company Information
7.2.2 Changtian Pharma Introduction and Business Overview
7.2.3 Changtian Pharma Pharmaceutical Activated Carbon Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Changtian Pharma Pharmaceutical Activated Carbon Product Offerings
7.2.5 Changtian Pharma Recent Development
7.3 Kureha
7.3.1 Kureha Company Information
7.3.2 Kureha Introduction and Business Overview
7.3.3 Kureha Pharmaceutical Activated Carbon Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Kureha Pharmaceutical Activated Carbon Product Offerings
7.3.5 Kureha Recent Development
7.4 Myvitamins
7.4.1 Myvitamins Company Information
7.4.2 Myvitamins Introduction and Business Overview
7.4.3 Myvitamins Pharmaceutical Activated Carbon Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Myvitamins Pharmaceutical Activated Carbon Product Offerings
7.4.5 Myvitamins Recent Development
8 Industry Chain Analysis
8.1 Pharmaceutical Activated Carbon Industrial Chain
8.2 Pharmaceutical Activated Carbon Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Activated Carbon Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Activated Carbon Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Activated Carbon market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 70
USD 4250.00
(Single User License)
The global Pharmaceutical Activated Carbon market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-05
Pages: 119
USD 2900.00
(Single User License)
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-05
Pages: 86
USD 3950.00
(Single User License)
The global Pharmaceutical Activated Carbon market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 72
USD 4250.00
(Single User License)
The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 125
USD 4900.00
(Single User License)
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 86
USD 3950.00
(Single User License)
The global market for Pharmaceutical Activated Carbon was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-19
Pages: 82
USD 2900.00
(Single User License)
The global Pharmaceutical Activated Carbon market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-04-17
Pages: 147
USD 5600.00
(Single User License)
The global Pharmaceutical Activated Carbon market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
Published Date: 2024-04-16
Pages: 132
USD 5900.00
(Single User License)
The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-07
Pages: 74
USD 4900.00
(Single User License)
The global Pharmaceutical Activated Carbon market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 70
The global Pharmaceutical Activated Carbon market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-05
Pages: 119
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-05
Pages: 86
The global Pharmaceutical Activated Carbon market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 72
The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 125
The global market for Pharmaceutical Activated Carbon was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 86
The global market for Pharmaceutical Activated Carbon was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-19
Pages: 82
The global Pharmaceutical Activated Carbon market size was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-04-17
Pages: 147
The global Pharmaceutical Activated Carbon market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
Published: 2024-04-16
Pages: 132
The global Pharmaceutical Activated Carbon market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-07
Pages: 74
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now